Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004197759 | SCV003694357 | uncertain significance | not specified | 2022-01-19 | criteria provided, single submitter | clinical testing | The c.409C>A (p.R137S) alteration is located in exon 4 (coding exon 4) of the SPTA1 gene. This alteration results from a C to A substitution at nucleotide position 409, causing the arginine (R) at amino acid position 137 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003140201 | SCV003822635 | uncertain significance | not provided | 2022-05-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003140201 | SCV004521227 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing |